Mechanical circulatory support devices as destination therapy-current evidence

about

Late Complications Following Continuous-Flow Left Ventricular Assist Device Implantation

P2860

Q26782700-31CD35D0-C632-42B8-803C-D9F26D2740D2

P2860

Mechanical circulatory support devices as destination therapy-current evidence

Item

http://www.wikidata.org/entity/Q38276527

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Mechanical circulatory support devices as destination therapy-current evidence

@en

type

Item

label

Mechanical circulatory support devices as destination therapy-current evidence

@en

prefLabel

Mechanical circulatory support devices as destination therapy-current evidence

@en

P1476

Mechanical circulatory support devices as destination therapy-current evidence

@en

P2093

Erik Rehn

http://www.w3.org/2001/XMLSchema#string

Jan Gummert

http://www.w3.org/2001/XMLSchema#string

Jochen Börgermann

http://www.w3.org/2001/XMLSchema#string

Kavous Hakim-Meibodi

http://www.w3.org/2001/XMLSchema#string

Michael Schoenbrodt

http://www.w3.org/2001/XMLSchema#string

Michiel Morshuis

http://www.w3.org/2001/XMLSchema#string

Stephan Ensminger

http://www.w3.org/2001/XMLSchema#string

Thomas Puehler

http://www.w3.org/2001/XMLSchema#string

P2860

Left ventricular assist device and drug therapy for the reversal of heart failure

Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices.

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.

Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.

Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.

Long-term use of a left ventricular assist device for end-stage heart failure.

Medical management of patients with continuous-flow left ventricular assist devices.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation?

P304

513-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2225-319X.2014.08.20

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269171294

http://www.w3.org/2001/XMLSchema#string

P698

25452913

http://www.w3.org/2001/XMLSchema#string

P932

4229463

http://www.w3.org/2001/XMLSchema#string

Mechanical circulatory support devices as destination therapy-current evidence

about

P2860

P2860

Mechanical circulatory support devices as destination therapy-current evidence

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932